We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Dr. Reddy's

News List

Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India prnasia
May 13, 2021
Dr. Reddy's Laboratories Ltd. and Shenzhen Pregene Biopharma Co., Ltd. today announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic of India for PRG1801, Pregene's single domain antibody-based anti-BCMA chimeric ...
Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies prnasia
January 28, 2021
Dr. Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) today announced results from an Avigan study on moderate-severe hospitalized COVID-19 patients in Kuwait.
Dr. Reddy's Launches Vigabatrin in the US biospectrumasia
August 21, 2019
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns fiercepharma
August 22, 2017
Dr. Reddy's is reviving the once well-known OTC back pain relief brand Doan's with a national TV and digital push.
Dr. Reddy's Expands Commercial Operations in Europe americanpharmaceuticalreview
February 10, 2017
Dr. Reddy's Laboratories Ltd. has announced the expansion of its commercial operations in Europe with the introduction of its portfolio of generics in France.